 |
|
The Influence of Adverse Drug Reactions on First-line Anti-tuberculosis Chemotherapy in the Elderly Patients.
Jeong Ihm Jeong, Bock Hyun Jung, Mi Hye Kim, Jae Min Lim, Dong Cheon Ha, Sung Won Cho, Dae Sik Rhui
Tuberc Respir Dis. 2009;67(4):325-330. Published online 2009 Oct 1 DOI: https://doi.org/10.4046/trd.2009.67.4.325
|
|
Citations to this article as recorded by
 Tuberculosis in older adults: challenges and best practices in the Western Pacific Region
Alvin Kuo Jing Teo, Fukushi Morishita, Tauhid Islam, Kerri Viney, Catherine W.M. Ong, Seiya Kato, HeeJin Kim, Yuhong Liu, Kyung Hyun Oh, Takashi Yoshiyama, Akihiro Ohkado, Kalpeshsinh Rahevar, Lisa Kawatsu, Manami Yanagawa, Kiesha Prem, Siyan Yi, Huong Th
The Lancet Regional Health - Western Pacific.2023; 36: 100770. CrossRef Evaluation of patient's experiences with daily DOTS
Akshaya Moorthy, Surabhi Jaggi, Kranti Garg, Mandeep Kaur Sodhi, Deepak Aggarwal, Jagdish Chander
Indian Journal of Tuberculosis.2022; 69(4): 453. CrossRef Ocular adverse events in drug sensitive TB patients on daily fixed dose combination anti-TB drugs: A record review study from Kerala, India
Muraleedharan Sarojini Manu, Kedar Mehta, Mrinalini Das, Shibu Balakrishnan, Mrithyunjayan Sunil kumar, P.S. Rakesh, M.P. Sindhu, Mathew J. Valamparampil, P.S. Neena, Srinath Satyanarayana
Indian Journal of Tuberculosis.2020; 67(2): 216. CrossRef Treatment outcomes for elderly patients in Thailand with pulmonary tuberculosis
Wilawan Somsong, Saranath Lawpoolsri, Yuthichai Kasetjaroen, Weerawat Manosuthi, Jaranit Kaewkungwal
Asian Biomedicine.2019; 12(2): 75. CrossRef Prevalence of adverse drug reaction with first-line drugs among patients treated for pulmonary tuberculosis
Abhijeet Singh, Rajendra Prasad, Viswesvaran Balasubramanian, Nikhil Gupta, Pawan Gupta
Clinical Epidemiology and Global Health.2015; 3: S80. CrossRef
|